Trends in heroin and pharmaceutical opioid overdose deaths in Australia

Drug and Alcohol Dependence

Volumn 179, Issue , 2017, Pages 291-298

  Roxburgh, Amanda ^a   Hall, Wayne D ^a,b,c,d   Dobbins, Timothy ^a   Gisev, Natasa ^a   Burns, Lucinda ^a   Pearson, Sallie ^e   Degenhardt, Louisa ^a,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Drug overdose; Fentanyl; Heroin; Morphine; Mortality; Opioid analgesics; Oxycodone; Prescription opioids

Indexed keywords

DIAMORPHINE; FENTANYL; NALOXONE; NARCOTIC ANALGESIC AGENT; OXYCODONE; TRAMADOL; DRUG; MORPHINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG MISUSE; DRUG OVERDOSE; FEMALE; HEALTH CARE ACCESS; HUMAN; MALE; MORTALITY; OPIATE ADDICTION; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; TREND STUDY;

ANALGESICS, OPIOID; AUSTRALIA; DRUG OVERDOSE; FENTANYL; HEROIN; HUMANS; MORPHINE; OPIOID-RELATED DISORDERS; OXYCODONE; PHARMACEUTICAL PREPARATIONS; TRAMADOL;

EID: 85027555850     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.07.018     Document Type: Article

References (42)

1. Australian Bureau of Statistics (2012). Estimated Resident Population by Single Year of Age, Australia [data file]. Retrieved from http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202012?OpenDocument.
2. Australian, Australian Institute of Health and Welfare, 2014. National Drug Strategy Household Survey Detailed Report 2013., 2014, AIHW, Canberra.
3. Berterame, S., Erthal, J., Thomas, J., Fellner, S., Vosse, B., Clare, P., Hao, W., Johnson, D.T., Mohar, A., Pavadia, J., Samak, A.K., Sipp, W., Sumyai, V., Suryawati, S., Toufiq, J., Yans, R., Mattick, R.P., Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 387 (2016), 1644–1656.
4. Bohnert, A., Valenstein, M., Bair, M.J., Ganoczy, D., McCarthy, J.F., Ilgen, M.A., Blow, F.C., Association between opioid prescribing patterns and opioid overdose-related Deaths. JAMA 305 (2011), 1315–1321.
5. Bugeja, L., Ibrahim, J.E., Ferrah, N., Murphy, B., Willoughby, M., Ranson, D., The utility of medico-legal databases for public health research: a systematic review of peer-reviewed publications using the National Coronial Information System. Health Res. Policy Syst., 2016, 10.1186/s12961-016-0096-1.
6. Calcaterra, S., Glanz, J., Binswanger, I.A., National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 131 (2013), 263–270.
7. Campbell, G., Nielsen, S., Larance, B., Bruno, R., Mattick, R.P., Hall, W.D., Lintzeris, N., Cohen, M., Smith, K., Degenhardt, L., Pharmaceutical opioid use and dependence among people living with chronic pain: associations Observed within the Pain and Opioids in Treatment (POINT) Cohort. Pain Med. 16 (2015), 1745–1758.
8. Coxe, S., West, S.G., Aiken, L.S., The analysis of count data: a gentle introduction to poisson regression and its alternatives. J. Pers. Assess. 91 (2009), 121–136, 10.1080/00223890802634175.
9. Darke, S., Mattick, R., Degenhardt, L., The ratio of non-fatal to fatal overdose. Addiction 98 (2003), 1169–1170.
10. Dart, R.C., Surratt, H.L., Cicero, T.J., Parrino, M.W., Severtson, S.G., Bucher-Bartelson, B., Green, J.L., Trends in opioid analgesic abuse and mortality in the United States. N. Engl J. Med. 72 (2015), 241–248.
11. Degenhardt, L., Dietze, P., Monograph No.10: Data Sources on Illicit Drug Use and Harm in Australia DPMP Monograph Series. 2005, Turning Point Alcohol and Drug Centre, Fitzroy.
12. Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., McLaren, J., Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 106 (2011), 32–51.
13. Degenhardt, L., Whiteford, H.A., Ferrari, A.J., Baxter, A.J., Charlson, F.J., Hall, W.D., Freedman, G., Burstein, R., Johns, N., Engell, R.E., Flaxman, A., Murray, C.J.L., Vos, T., Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 382 (2013), 1564–1574.
14. Degenhardt, L., Gisev, N., Cama, E., Nielsen, S., Larance, B., Bruno, R., The extent and correlates of community-based pharmaceutical opioid utilisation in Australia. Pharmacoepidemiol. Drug Saf. 25 (2016), 521–538.
15. Delcher, C., Wagenaar, A.C., Goldberger, B.A., Cook, R.L., Maldonado-Molinaa, M.M., Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program. Drug Alcohol Depend. 150 (2015), 63–68.
16. Drug Utilisation Sub-Committee (DUSC), Opioid Analgesics Overview. Public Release Report; DUSC Meeting., October 2014, Australian Government Department of Health, Canberra, 2014.
17. European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2016: Trends and Developments., 2016, Publications Office of the European Union, Luxembourg.
18. Fischer, B., Rehm, J., Prescription Opioids Misuse, Harms and Control in Canada: A Research and Policy Issues Brief for the Department of Justice. 2011, Centre for Applied Research in Mental Health and Addiction (CARMHA), Vancouver, BC.
19. Fischer, B., Jones, W., Rehm, J., Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: An update with a focus on recent interventions. BMC Health Serv. Res. 14 (2012), 90–98.
20. Fischer, B., Keates, A., ‘Opioid drought’, canadian-style? potential implications of the ‘natural experiment’ of delisting oxycontin in Canada. Int. J. Drug Policy 23 (2012), 495–497.
21. Fischer, B., Keates, A., Bühringer, G., Reimer, J., Rehm, J., Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?. Addiction 109 (2013), 177–181.
22. Gisev, N., Nielsen, S., Cama, E., Larance, B., Bruno, R., Degenhardt, L., An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia. Eur. J. Clin. Pharmacol. 72 (2016), 469–494.
23. Haegerich, T.M., Paulozzi, L.J., Manns, B.J., Jones, C.M., What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 145 (2014), 34–37.
24. Hollingworth, S.A., Gray, P.D., Hall, W.D., Najman, J.M., Opioid analgesic prescribing in Australia: a focus on gender and age. Pharmacoepidemiol. Drug Saf. 24 (2015), 628–636.
25. Johnson, E.M., Porucznik, C.A., Anderson, J.W., Rolfs, R.T., State-level strategies for reducing prescription drug overdose deaths: utah's prescription safety program. Pain Med. 12 (2011), S66–S72.
26. Karanges, E., Blanch, B., Buckley, N.A., Pearson, S.A., Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Br. J. Clin. Pharmacol. 82 (2016), 255–267.
27. Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Ali, R., Mattick, R.P., Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours (invited paper). Drug Alcohol Rev. 30 (2011), 236–245.
28. Larance, B., Dobbins, T., Peacock, A., Ali, R., Bruno, R., Lintzeris, N., Farrell, M., Degenhardt, L., The Impacts of a Potentially Tamper-resistant Oxycodone Formulation on Opioid Use and Harms: Main Findings from the National Opioid Medications Abuse Deterrence (NOMAD) Study. 2017 (in preparation).
29. Lenton, S., Dietze, P., Jauncey, M., Australia reschedules naloxone for opioid overdose. Med. J. Aust. 204 (2016), 146–147e1.
30. Martins, S.S., Sampson, L., Cerdá, M., Galea, S., Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am. J. Public Health 105 (2015), e29–e49.
31. McCauley, J.L., Back, S.E., Brady, K.T., Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids. Addict. Behav. 38 (2013), 2230–2235.
32. Mellish, L., Karanges, E.A., Litchfield, M.J., Schaffer, A.L., Blanch, B., Daniels, B.J., Segrave, A., Pearson, S.A., The Australian Pharmaceutical Benefits Scheme Data Collection. A Practical Guide for Researchers, vol 8, 2015, BMC Res. Notes, 634, 10.1186/s13104-015-1616-8.
33. Nielsen, S., Degenhardt, L., Hoban, B., Gisev, N., A synthesis of oral morphine equivalents (OME) for opioid utilisation studies, Pharmacoepidemiol. Drug Saf. 25 (2016), 733–737.
34. Ogeil, R.P., Heilbronn, C., Lloyd, B., Lubman, D., Prescription drug monitoring in Australia: capacity and coverage issues. Med. J. Aust., 204, 2016 148–148e1.
35. Paulozzi, L., Budnitz, D., Yongli, X., Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol. Drug Saf. 15 (2006), 618–627.
36. Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increases in drug and opioid overdose deaths — United States. 2000-2014 Morbidity and Mortality Weekly Report, 2016, Centers for Disease Control and Prevention, Washington D.C.
37. Stafford, J., Breen, C., Australian Drug Trends 2015: Findings from the Illicit Drug Reporting System (IDRS)., 2016, National Drug and Alcohol Research Centre, UNSW, Sydney.
38. Strang, J., Hall, W.D., Hickman, M., Bird, S., Impact of supervision of methadone consumption on deaths related to methadone overdose (1993–2008): Analyses using OD4 index in England and Scotland. BMJ 341 (2010), 4851–4857.
39. Tjagvad, C., Skurtveit, S., Bramness, J.G., Gjersing, L., Gossop, M., Clausen, T., Misuse of prescription drugs and overdose deaths. J. Subst. Use 21 (2016), 515–520, 10.3109/14659891.2015.1077280.
40. Walley, A.Z.X., H, H.H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., Ozonoff, A., Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interupted time seriesanalysis. BMJ, 346, 2013, f174.
41. Weintraub, M., Singh, S., Byrne, L., Maharaj, K., Guttmacher, L., Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA 266 (1991), 2392–2397.
42. World Health Organization, website ? http://www. who. int/topics/mortality/en/- accessed 5 December 2016.